Paper35281985
Safety of Intraparenchymal Injection of Allogenic Placenta Mesenchymal Stem Cells Derived Exosome in Patients Undergoing Decompressive Craniectomy Following Malignant Middle Cerebral Artery Infarct, A Pilot Randomized Clinical Trial.
Dehghani L and 9 others. Int J Prev Med, 2022. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. Safety of Intraparenchymal Injection of Allogenic Placenta Mesenchymal Stem Cells Derived Exosome in Patients Undergoing Decompressive Craniectomy Following Malignant Middle Cerebral Artery Infarct, A Pilot Randomized Clinical Trial. Papers, record 35281985. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35281985
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Safety of Intraparenchymal Injection of Allogenic Placenta Mesenchymal Stem Cells Derived Exosome in Patients Undergoing Decompressive Craniectomy Following Malignant Middle Cerebral Artery Infarct, A Pilot Randomized Clinical Trial.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT07398612 | Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke | Background |
Source ClinicalTrials.gov
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32935221 | Stem Cell-Derived Exosomes as Treatment for Stroke: a Systematic Review. | Stem Cell Rev Rep | 2021 | https://conductscience.org/library/papers/32935221 | PubMed |
| 2 | 21231804 | Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy. | Cytotherapy | 2011 | https://conductscience.org/library/papers/21231804 | PubMed |
| 3 | 21636813 | Recombinant tissue-type plasminogen activator use for ischemic stroke in the United States: a doubling of treatment rates over the course of 5 years. | Stroke | 2011 | https://conductscience.org/library/papers/21636813 | PubMed |
| 4 | 25671797 | Endovascular therapy for ischemic stroke with perfusion-imaging selection. | N Engl J Med | 2015 | https://conductscience.org/library/papers/25671797 | PubMed |
| 5 | 32962207 | Pleiotropic Effects of Exosomes as a Therapy for Stroke Recovery. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32962207 | PubMed |
| 6 | 25554246 | Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. | Syst Rev | 2015 | https://conductscience.org/library/papers/25554246 | PubMed |
| 7 | 24000286 | MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation. | Stem Cells Int | 2013 | https://conductscience.org/library/papers/24000286 | PubMed |
| 8 | 31943851 | Exosomal 2',3'-CNP from mesenchymal stem cells promotes hippocampus CA1 neurogenesis/neuritogenesis and contributes to rescue of cognition/learning deficiencies of damaged brain. | Stem Cells Transl Med | 2020 | https://conductscience.org/library/papers/31943851 | PubMed |
| 9 | 12728267 | Mechanisms, challenges and opportunities in stroke. | Nat Rev Neurosci | 2003 | https://conductscience.org/library/papers/12728267 | PubMed |
| 10 | 30500591 | Decompressive Hemicraniectomy in the Treatment of Malignant Middle Cerebral Artery Infarction: A Meta-Analysis. | World Neurosurg | 2019 | https://conductscience.org/library/papers/30500591 | PubMed |
| 11 | 20354047 | Malignant middle cerebral artery (MCA) infarction: pathophysiology, diagnosis and management. | Postgrad Med J | 2010 | https://conductscience.org/library/papers/20354047 | PubMed |
| 12 | 23963371 | Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats. | J Cereb Blood Flow Metab | 2013 | https://conductscience.org/library/papers/23963371 | PubMed |
| 13 | 28300134 | White Matter Repair After Extracellular Vesicles Administration in an Experimental Animal Model of Subcortical Stroke. | Sci Rep | 2017 | https://conductscience.org/library/papers/28300134 | PubMed |
| 14 | 26088123 | White matter injury restoration after stem cell administration in subcortical ischemic stroke. | Stem Cell Res Ther | 2015 | https://conductscience.org/library/papers/26088123 | PubMed |
| 15 | 26339036 | Extracellular Vesicles Improve Post-Stroke Neuroregeneration and Prevent Postischemic Immunosuppression. | Stem Cells Transl Med | 2015 | https://conductscience.org/library/papers/26339036 | PubMed |
| 16 | 27793019 | Intravenous administration of xenogenic adipose-derived mesenchymal stem cells (ADMSC) and ADMSC-derived exosomes markedly reduced brain infarct volume and preserved neurological function in rat after acute ischemic stroke. | Oncotarget | 2016 | https://conductscience.org/library/papers/27793019 | PubMed |
| 17 | 17303527 | Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. | Lancet Neurol | 2007 | https://conductscience.org/library/papers/17303527 | PubMed |
| 18 | 24991475 | Hemicraniectomy in the management of malignant middle cerebral artery infarction: Lessons from randomized, controlled trials. | Surg Neurol Int | 2014 | https://conductscience.org/library/papers/24991475 | PubMed |
| 19 | 14707232 | Hemicraniectomy for massive middle cerebral artery territory infarction: a systematic review. | Stroke | 2004 | https://conductscience.org/library/papers/14707232 | PubMed |
| 20 | 30637094 | Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. | J Extracell Vesicles | 2018 | https://conductscience.org/library/papers/30637094 | PubMed |
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42811655 | Targeting Microglial HDAC5 Suppresses NLRP3 Inflammation via NF-κB Deacetylation to Alleviate Ischemic Brain Injury. | CNS Neurosci Ther | 2026 | https://conductscience.org/library/papers/42811655 | PubMed |
| 42750825 | Extracellular vesicle-based therapeutic strategies for spinal tumors and associated nerve damage: advances, challenges, and future directions. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42750825 | PubMed |
| 42481878 | Target therapeutic exploitation of engineered exosome-mediated delivery of ncRNAs in cancer. | Cancer Gene Ther | 2026 | https://conductscience.org/library/papers/42481878 | PubMed |
| 42454198 | A multidimensional landscape of extracellular vesicle-mediated tumor drug resistance: mechanisms, biomarkers, engineered drug delivery, and clinical translation. | Extracell Vesicles Circ Nucl Acids | 2026 | https://conductscience.org/library/papers/42454198 | PubMed |
| 42394789 | Mesenchymal stem cells-derived extracellular vesicles as a novel drug delivery carrier: engineering strategies and clinical safety estimation. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42394789 | PubMed |
| 41379301 | The Potential of Neural Stem Cell-derived Exosomes for the Treatment of Ischemic Stroke. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/41379301 | PubMed |
| 41169215 | Intercellular communication between peripheral monocytes and central nervous system cells in stroke. | Neural Regen Res | 2026 | https://conductscience.org/library/papers/41169215 | PubMed |
| 41104040 | Extracellular vesicles for the delivery of gene therapy. | Nat Rev Bioeng | 2025 | https://conductscience.org/library/papers/41104040 | PubMed |
| 41084287 | Stem Cell-Derived Extracellular Vesicle Therapy in Ischemic Brain Injuries. | J Stroke | 2025 | https://conductscience.org/library/papers/41084287 | PubMed |
| 40999517 | Fucoxanthin protects placenta-derived human mesenchymal stem cells against oxidative stress-induced apoptosis by modulating genes involved in DNA damage repair, ER stress response, p53-induced apoptosis. | Stem Cell Res Ther | 2025 | https://conductscience.org/library/papers/40999517 | PubMed |
| 40804047 | Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies. | Signal Transduct Target Ther | 2025 | https://conductscience.org/library/papers/40804047 | PubMed |
| 40643679 | Advances in brain remodeling, stem cell therapies, and translational barriers in stroke and brain aging. | Biogerontology | 2025 | https://conductscience.org/library/papers/40643679 | PubMed |
| 40264776 | Extracellular vesicles as precision therapeutics for psychiatric conditions: targeting interactions among neuronal, glial, and immune networks. | Front Immunol | 2025 | https://conductscience.org/library/papers/40264776 | PubMed |
| 39918683 | Roles and Potential Mechanisms of Endothelial Cell-Derived Extracellular Vesicles in Ischemic Stroke. | Transl Stroke Res | 2025 | https://conductscience.org/library/papers/39918683 | PubMed |
| 39871579 | Extracellular vesicles as drug and gene delivery vehicles in central nervous system diseases. | Biomater Sci | 2025 | https://conductscience.org/library/papers/39871579 | PubMed |
| 39865337 | Noninvasive in vivo imaging of macrophages: understanding tumor microenvironments and delivery of therapeutics. | Biomark Res | 2025 | https://conductscience.org/library/papers/39865337 | PubMed |
| 39771472 | Molecular Targeting of Ischemic Stroke: The Promise of Naïve and Engineered Extracellular Vesicles. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39771472 | PubMed |
| 39721917 | Mitochondrial-targeted therapies in traumatic brain injury: From bench to bedside. | Neurotherapeutics | 2025 | https://conductscience.org/library/papers/39721917 | PubMed |
| 39703170 | Critical roles of extracellular vesicles in periodontal disease and regeneration. | Stem Cells Transl Med | 2025 | https://conductscience.org/library/papers/39703170 | PubMed |
| 39508049 | Stem cell-derived exosomes for ischemic stroke: a conventional and network meta-analysis based on animal models. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39508049 | PubMed |
Genes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35281985
GET https://conductscience.org/api/papers/v1/35281985/references?page=2